Tag: ip
-
Supreme Court Case Amgen Inc. v. Sanofi Summary and Its Implication in Biotech Patents
The United States Supreme Court case, Amgen Inc. v. Sanofi, has significant implications for patent law, particularly in the realm of pharmaceuticals and biotechnology. This case revolved around the enablement requirement of the Patent Act, 35 U.S.C. § 112 (a). Background Amgen and Sanofi, two pharmaceutical giants, each obtained a patent in 2011 for the antibody…
-
The Minerva Surgical, Inc. v. Hologic, Inc. Case: A Landmark Decision in Patent Law
The Supreme Court’s decision in Minerva Surgical, Inc. v. Hologic, Inc. has far-reaching implications for patent law, particularly concerning the doctrine of assignor estoppel. This case, decided in June 2021, centered around the question of whether the doctrine of assignor estoppel should be retained, modified, or eliminated altogether. This blog post provides an overview of the case,…
-
Understanding the Impact of Thryv, Inc. v. Click-to-Call Technologies on Patent Litigation
The Supreme Court’s decision in Thryv, Inc. v. Click-to-Call Technologies has significant implications for the landscape of patent litigation, particularly concerning the doctrine of inter partes review (IPR). This case, decided in April 2020, addressed the question of whether the Patent Trial and Appeal Board (PTAB) can determine whether a petition for IPR is timely…
EPIMED RESEARCH 